1 year return (CAGR)
-43.07%
Bicara Therapeutics Inc. Common Stock Exchange (NASDAQ, USD)
BCAX
9.73
-0.03 (-0.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
643.86M
Price/Sales
-
Ent value
590.74M
Price/Book
1.37
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.79 |
| Daily high | 10.19 |
| Daily low | 9.35 |
| Daily Volume | 3.18M |
| All-time high | 30.40 |
| 1y analyst estimate | 35.50 |
| Beta | -0.82 |
| EPS (TTM) | -2.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| BCAX | S&P500 | |
| Current price drop from All-time high | -67.99% | -1.25% |
| Highest price drop | -67.99% | -56.47% |
| Date of highest drop | 29 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -36.57% | -10.65% |
| Avg time to new high | 76 days | 12 days |
| Max time to new high | 445 days | 1805 days |
News
